The observed trend with CRP levels further suggests the atherosclerosis mechanism at play as CRP is a well-established acute phase reactant and biomarker of systemic inflammation, which contributes to the initiation, progression, and destabilisation of atherosclerotic plaques and ultimately CVD [38]. Here, CRP is linked to atherosclerosis.